Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Lung Cancer
>
2018
>
21
>
6
Volume:
21
Issue:
6
1. Progress of Lung Margin During Sublobar Resection for Early-staged Non-small Cell Lung Cancer.
Page:498—502
2. Advance of Treatment for Superior Sulcus Tumor of the Lung.
Page:493—497
3. Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer.
Page:481—492
4. Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy.
Page:476—480
5. Bioinformatics Analysis of DNA Methylation in the Promoters of LincRNA in Lung Adenocarcinoma.
Page:470—475
6. Risk Factors of Nodal Upstaging in Clinical Ia Lung Adenocarcinoma.
Page:463—469
7. Severe Adverse Reactions Induced by the Chest Injection of Elemene: An Analysis of 7 Cases.
Page:458—462
8. Value of CT Features on Differential Diagnosis of Pulmonary Subsolid Nodules and Degree of invasion Prediction in Pulmonary Adenocarcinoma.
Page:451—457
9. Expression and Clinical Significance of LC-3 and P62 in Non-small Cell Lung Cancer.
Page:445—450
10. Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated with More Than Two Lines of Chemotherapy.
Page:437—444
11. Expression of Acetaldehyde Dehydrogenase in Gefitinib-resistant Human Lung Adenocarcinoma HCC-827/GR Cells.
Page:431—436